Multiple system organ response induced by Hyperoxia in a clinically relevant animal model of sepsis

Shock

Volumn 42, Issue 2, 2014, Pages 148-153

  Rodríguez González, Raquel ^a,b,c   Martín Barrasa, José Luis ^b   Ramos Nuez, Ángela ^a,b   Cañas Pedrosa, Ana María ^d   Martínez Saavedra, María Teresa ^e   García Bello, Miguel Ángel ^b   López Aguilar, Josefina ^f   Baluja, Aurora ^c   Álvarez, Julián ^c   Slutsky, Arthur S ^c   Villar, Jesús ^a,g  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b HOSPITAL UNIVERSITARIO DE GRAN CANARIA DR NEGRÍN   (Spain)

^c UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^d Departments of Microbiology   (United States)

^e Departments of Immunology   (Colombia)

^f Critical Care Center   (Spain)

^g ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

infection; inflammation; multiple system organ dysfunction; oxygen therapy; reactive oxygen species; Sepsis

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 6; REACTIVE OXYGEN METABOLITE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; AUTACOID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HYPEROXIA; INFECTION; INFLAMMATION; LUNG LAVAGE; MALE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXYGEN THERAPY; RAT; SEPSIS; THROMBOCYTE COUNT; ANIMAL; BLOOD; COMPLICATION; DISEASE COURSE; DISEASE MODEL; IMMUNOLOGY; LEUKOCYTE COUNT; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HYPEROXIA; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MULTIPLE ORGAN FAILURE; OXYGEN INHALATION THERAPY; PLATELET COUNT; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SEPSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84904670919     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0000000000000189     Document Type: Article

References (33)

1. Blanco J, Muriel-Bombin A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, et al: Grupo de Estudios y Analisis en Cuidados Intensivos. Incidence, organ dysfunction and mortality in severe sepsis: A Spanish multicentre study. Crit Care 12(6):R158, 2008.
2. Cohen J: The immunopathogenesis of sepsis. Nature 420(6917):885-891, 2002.
3. Carrico CJ, Meakins JL, Marshall JC, Fry D, Maier RV: Multiple-organ-failure syndrome. Arch Surg 121(2):196-208, 1986.
4. Villar J, Manzano JJ, Blazquez MA, Quintana J, Lubillo S: Multiple system organ failure in acute respiratory failure. J Crit Care 6(2):75-80, 1991.
5. Riedermann NC, Guo RF, Ward PA: The enigma of sepsis. J Clin Invest 112(4):460-467, 2003.
6. Buras JA, Holt D, Orlow D, Belikoff B, Pavlides S, Reenstra WR: Hyperbaric oxygen protects from sepsis mortality via an interleukin-10-dependent mechanism. Crit Care Med 34(10):2624-2629, 2006.
7. Waisman D, Brod V, Rahat MA, Amit-Cohen BC, Lahat N, Rimar D, Menn-Josephy H, David M, Lavon O, Cavari Y, et al: Dose-related effects of hyperoxia on the lung inflammatory response in septic rats. Shock 37(1):95-102, 2012.
8. Barth E, Bassi G, Maybauer DM, Simon F, Gröger M, Oter S, SpeitG,NguyenCD, Hasel C, Möller P, et al: Effects of ventilation with 100% oxygen during early hyperdynamic porcine fecal peritonitis. Crit Care Med 36(2):495-503, 2008.
9. Altemeier WA, Sinclair SE: Hyperoxia in the intensive care unit: why more is not always better. Curr Opin Crit Care 13(1):73-78, 2007.
10. Asfar P, Calzia E, Huber-Lang M, Ignatius A, Radermacher P: Hyperoxia during septic shockVDr. Jekyll or Mr. Hyde? Shock 37(1):122-123, 2012.
11. Nathan C, Cunningham-Bussel A: Beyond oxidative stress: An immunologists guide to reactive oxygen species. Nat Rev Immunol 13(5):349-361, 2013.
12. Cowley HC, Bacon PJ, Goode HF, Webster NR, Jones JG, Menon DK: Plasma antioxidant potential in severe sepsis: A comparison of survivors and nonsurvivors. Crit Care Med 24(7):1179-1183, 1996.
13. Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF: Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30(8):1782-1786, 2002.
14. Alonso de Vega JM, Díaz J, Serrano E, Carbonell LF: Plasma redox status relates to severity in critically ill patients. Crit Care Med 28(6):1812-1814, 2000.
15. Ware LB, Fessel JP, May AK, Roberts LJ 2nd: Plasma biomarkers of oxidant stress and development of organ failure in severe sepsis. Shock 36(1):12-17, 2011.
16. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG: Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. PLoS Biology 8(6):e1000412, 2010.
17. Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA: Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 4(1):31-36, 2009.
18. Villar J, Ribeiro SP, Mullen JBM, Kuliszewski M, Post M, Slutsky AS: Induction of the heat shock response reduces mortality rate and organ damage in a sepsis-induced acute lung injury model. Crit Care Med 22(6):914-921, 1994.
19. Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, et al: Surviving Sepsis Campaign Guidelines Committee including the Pediatric Subgroup: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 41(2):580-637, 2013.
20. Thiel M, Chouker A, Ohta A, Jackson E, Caldwell C, Smith P, Lukashev D, Bittmann I, Sitkovsky MV: Oxygenation inhibits the physiological tissueprotecting mechanism and thereby exacerbates acute inflammatory lung injury. PLoS Biol 3(6):e174, 2005.
21. HouL, XieK,QinM, Peng D, Ma S, Shang L, LiN, Li S, JiG, LuY, et al: Effects of reactive oxygen species scavenger on the protective action of 100% oxygen treatment against sterile inflammation in mice. Shock 33(6):646-654, 2010.
22. Xie K, Fu W, Xing W, Li A, Chen H, Han H, Yu Y, Wang G: Combination therapy with molecular hydrogen and hyperoxia in a murine model of polymicrobial sepsis. Shock 38(6):656-663, 2012.
23. Gofton TE, Young GB: Sepsis-associated encephalopathy. Nat Rev Neurol 8(10):557-566, 2012.
24. Avtan SM, Kaya M, Orhan N, Arslan A, Arican N, Toklu AS, Gürses C, Elmas I, Kucuk M, Ahishali B: The effects of hyperbaric oxygen therapy on bloodbrain barrier permeability in septic rats. Brain Res 1412:63-72, 2011.
25. Flierl MA, Rittirsch D, Gao H, Hoesel LM, Nadeau BA, Day DE, Zetoune FS, Sarma JV, Huber-Lang MS, Ferrara JL, et al: Adverse functions of IL-17A in experimental sepsis. FASEB J 22(7):2198-2205, 2008.
26. Gao M, Zhang L, Liu Y, Yang M, Wang N, Wang K, Ou D, Liu M, Chen G, Liu K, et al: Use of blood urea nitrogen, creatinine, interleukin-6, granulocytemacrophage colony stimulating factor in combination to predict the severity and outcome of abdominal sepsis in rats. Inflamm Res 61(8):889-897, 2012.
27. Petillä V, Hynninen M, Takkunen O, Kuusela P, Valtonen M: Predictive value of procalcitonin and interleukin 6 in critically ill patients with suspected sepsis. Intensive Care Med 28(9):1220-1225, 2002.
28. van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frölich M: Anti-inflammatory cytokine profile and mortality in febrile patients. Lancet 351(9107):950-953, 1998.
29. Gogos CA, Drosou E, Bassaris HP, Skoutelis A: Pro-versus anti-inflammatory cytokine profile in patients with severe sepsis: A marker for prognosis and future therapeutic options. J Infect Dis 181(1):176-180, 2000.
30. Monneret G, Finck ME, Venet F, Debard AL, Bohé J, Bienvenu J, Lepape A: The anti-inflammatory response dominates after septic shock: Association of low monocyte HLA-DR expression and high interleukin-10 concentration. Immunol Lett 95(2):193-198, 2004.
31. Kellum JA, Kong L, Fink MP, Weissfeld LA, Yealy DM, Pinsky MR, Fine J, Krichevsky A, Delude RL, Angus DC; GenIMS Investigators: Understanding the inflammatory cytokine response in pneumonia and sepsis: results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study. Arch Intern Med 167(15):1655-1663, 2007.
32. Semeraro N, Ammollo CT, Semeraro F, Colucci M: Sepsis, thrombosis and organ dysfunction. Thromb Res 129(3):290-295, 2012.
33. Ayala A, Chaudry IH: Immune dysfunction in murine polymicrobial sepsis: mediators, macrophages, lymphocytes and apoptosis. Shock 6(Suppl 1): S27-S38, 1996.